Cargando…

Systemic therapies for unresectable locoregional melanoma: a significant area of need

Immune checkpoint inhibitors and BRAF-MEK inhibitors have revolutionized the management and prognosis of patients with metastatic melanoma. However, there is minimal evidence to guide their incorporation into current treatment paradigms for unresectable stage III disease. The era of effective system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nan Tie, Emilia, Lai-Kwon, Julia E, Gyorki, David E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891929/ https://www.ncbi.nlm.nih.gov/pubmed/31807276 http://dx.doi.org/10.2217/mmt-2019-0010

Ejemplares similares

Locoregional melanoma: identifying optimal care in a rapidly changing landscape
por: Gyorki, David E, et al.
Publicado: (2019)

Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms
por: Iezzi, Roberto, et al.
Publicado: (2021)

Efficacy of immune checkpoint inhibitors for in-transit melanoma
por: Nan Tie, Emilia, et al.
Publicado: (2020)

Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
por: Zhang, Mengqi, et al.
Publicado: (2023)

Prospective results of concurrent radiation therapy and weekly paclitaxel as salvage therapy for unresectable locoregionally recurrent breast cancer
por: Cai, Gang, et al.
Publicado: (2019)

How we treat locoregional melanoma
por: Troiani, T., et al.
Publicado: (2021)

The delicate balance of melanoma immunotherapy
por: Gyorki, David E, et al.
Publicado: (2013)

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy
por: Blankenstein, Stephanie A., et al.
Publicado: (2020)

Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress
por: DePalo, Danielle K., et al.
Publicado: (2023)

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
por: Teterycz, Pawel, et al.
Publicado: (2019)

Efficacy of Iodine-125 Seed Implantation in Locoregionally Recurrent and Unresectable Breast Cancer: a Retrospective Study
por: Yu, Ying-hua, et al.
Publicado: (2017)

Locoregional therapy of renal cancer
por: Wah, Tze Min
Publicado: (2014)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023)

Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma
por: Yeh, Jennifer E., et al.
Publicado: (2022)

Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it
por: Qu, Weiling, et al.
Publicado: (2022)

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
por: Guadagni, Stefano, et al.
Publicado: (2017)

The neutrophil–lymphocyte ratio and locoregional melanoma: a multicentre cohort study
por: Robinson, Alyss V., et al.
Publicado: (2020)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Update on Locoregional Therapies for Cholangiocellular Carcinoma
por: Morawitz, Janna, et al.
Publicado: (2023)

The role of adjuvant radiation therapy for locoregionally recurrent papillary thyroid carcinoma
por: Hwang, Hyun, et al.
Publicado: (2021)

Metastatic disease to the liver: Locoregional therapy strategies and outcomes
por: Zane, Kylie E, et al.
Publicado: (2021)

Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?
por: De Bari, Berardino, et al.
Publicado: (2022)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Complications following locoregional therapy of renal cancer
por: Krokidis, Miltiadis
Publicado: (2014)

Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
por: Bazeed, Alaa Y., et al.
Publicado: (2022)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
por: Podlasek, Anna, et al.
Publicado: (2023)

New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy
por: Mauro, Ezequiel, et al.
Publicado: (2023)

Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma
por: Chami, Perla, et al.
Publicado: (2023)

Concomitant fulvestrant with reirradiation for unresectable locoregional recurrent estrogen receptor positive (ER+) breast cancer: A case report and narrative review
por: Ding, Jingxian, et al.
Publicado: (2020)

Locoregional Approaches in Cholangiocarcinoma Treatment
por: Hare, Alexander E., et al.
Publicado: (2022)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
por: Yeh, Jennifer E., et al.
Publicado: (2022)

Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020)

Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma
por: Serra, Francesco, et al.
Publicado: (2021)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma: The Role of Intra-Arterial Therapies
por: Gorji, Leva, et al.
Publicado: (2023)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Prognostic significance of the systemic immune inflammation index in patients with metastatic and unresectable pancreatic cancer
por: Han, Rongshuang, et al.
Publicado: (2022)

MRI assessment of hepatocellular carcinoma after locoregional therapy
por: Hussein, Rasha S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_danmuava2ke549nscltq0r2lpj